C型肝炎治療薬の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR2784)
◆英語タイトル:Global Hepatitis C Drugs Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR2784
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:98
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品、ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、C型肝炎治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(抗ウイルス剤、免疫調節剤、その他)、用途別市場規模(病院、クリニック)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・C型肝炎治療薬の市場動向
・企業の競争状況、市場シェア
・C型肝炎治療薬の種類別市場規模(抗ウイルス剤、免疫調節剤、その他)
・C型肝炎治療薬の用途別市場規模(病院、クリニック)
・C型肝炎治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・C型肝炎治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・C型肝炎治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・C型肝炎治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・C型肝炎治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Gilead sciences、Abbvi、Johnson & Johnson、Merck、Glaxosmithkline、Novartis、Bristol-Myers Squibb、Roche)
・結論
【レポートの概要】

Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay colored stools etc.
Hepatitis is caused by a variety of factors both microbial and non-microbial. However hepatitis C is caused by hepatitis C virus and affects between 130–150 million people globally every year of which approximately 700 000 people die from hepatitis C-related liver diseases. What is of greater concern is the fact that 15 to 20% of chronically infected patients develop liver cirrhosis or liver cancer.

Market Analysis and Insights: Global Hepatitis C Drugs Market
The global Hepatitis C Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hepatitis C Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hepatitis C Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hepatitis C Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hepatitis C Drugs market.

Global Hepatitis C Drugs Scope and Market Size
Hepatitis C Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis C Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anti-Viral
Immuno-modulators
Others

Segment by Application
Hospitals
Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Gilead sciences
Abbvi
Johnson & Johnson
Merck
Glaxosmithkline
Novartis
Bristol-Myers Squibb
Roche

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis C Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-Viral
1.2.3 Immuno-modulators
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hepatitis C Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hepatitis C Drugs Market Perspective (2016-2027)
2.2 Hepatitis C Drugs Growth Trends by Regions
2.2.1 Hepatitis C Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hepatitis C Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Hepatitis C Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Hepatitis C Drugs Industry Dynamic
2.3.1 Hepatitis C Drugs Market Trends
2.3.2 Hepatitis C Drugs Market Drivers
2.3.3 Hepatitis C Drugs Market Challenges
2.3.4 Hepatitis C Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hepatitis C Drugs Players by Revenue
3.1.1 Global Top Hepatitis C Drugs Players by Revenue (2016-2021)
3.1.2 Global Hepatitis C Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Hepatitis C Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hepatitis C Drugs Revenue
3.4 Global Hepatitis C Drugs Market Concentration Ratio
3.4.1 Global Hepatitis C Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Drugs Revenue in 2020
3.5 Hepatitis C Drugs Key Players Head office and Area Served
3.6 Key Players Hepatitis C Drugs Product Solution and Service
3.7 Date of Enter into Hepatitis C Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hepatitis C Drugs Breakdown Data by Type
4.1 Global Hepatitis C Drugs Historic Market Size by Type (2016-2021)
4.2 Global Hepatitis C Drugs Forecasted Market Size by Type (2022-2027)

5 Hepatitis C Drugs Breakdown Data by Application
5.1 Global Hepatitis C Drugs Historic Market Size by Application (2016-2021)
5.2 Global Hepatitis C Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hepatitis C Drugs Market Size (2016-2027)
6.2 North America Hepatitis C Drugs Market Size by Type
6.2.1 North America Hepatitis C Drugs Market Size by Type (2016-2021)
6.2.2 North America Hepatitis C Drugs Market Size by Type (2022-2027)
6.2.3 North America Hepatitis C Drugs Market Size by Type (2016-2027)
6.3 North America Hepatitis C Drugs Market Size by Application
6.3.1 North America Hepatitis C Drugs Market Size by Application (2016-2021)
6.3.2 North America Hepatitis C Drugs Market Size by Application (2022-2027)
6.3.3 North America Hepatitis C Drugs Market Size by Application (2016-2027)
6.4 North America Hepatitis C Drugs Market Size by Country
6.4.1 North America Hepatitis C Drugs Market Size by Country (2016-2021)
6.4.2 North America Hepatitis C Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hepatitis C Drugs Market Size (2016-2027)
7.2 Europe Hepatitis C Drugs Market Size by Type
7.2.1 Europe Hepatitis C Drugs Market Size by Type (2016-2021)
7.2.2 Europe Hepatitis C Drugs Market Size by Type (2022-2027)
7.2.3 Europe Hepatitis C Drugs Market Size by Type (2016-2027)
7.3 Europe Hepatitis C Drugs Market Size by Application
7.3.1 Europe Hepatitis C Drugs Market Size by Application (2016-2021)
7.3.2 Europe Hepatitis C Drugs Market Size by Application (2022-2027)
7.3.3 Europe Hepatitis C Drugs Market Size by Application (2016-2027)
7.4 Europe Hepatitis C Drugs Market Size by Country
7.4.1 Europe Hepatitis C Drugs Market Size by Country (2016-2021)
7.4.2 Europe Hepatitis C Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hepatitis C Drugs Market Size (2016-2027)
8.2 Asia-Pacific Hepatitis C Drugs Market Size by Type
8.2.1 Asia-Pacific Hepatitis C Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hepatitis C Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hepatitis C Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Hepatitis C Drugs Market Size by Application
8.3.1 Asia-Pacific Hepatitis C Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hepatitis C Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hepatitis C Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Hepatitis C Drugs Market Size by Region
8.4.1 Asia-Pacific Hepatitis C Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hepatitis C Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hepatitis C Drugs Market Size (2016-2027)
9.2 Latin America Hepatitis C Drugs Market Size by Type
9.2.1 Latin America Hepatitis C Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Hepatitis C Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Hepatitis C Drugs Market Size by Type (2016-2027)
9.3 Latin America Hepatitis C Drugs Market Size by Application
9.3.1 Latin America Hepatitis C Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Hepatitis C Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Hepatitis C Drugs Market Size by Application (2016-2027)
9.4 Latin America Hepatitis C Drugs Market Size by Country
9.4.1 Latin America Hepatitis C Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Hepatitis C Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hepatitis C Drugs Market Size (2016-2027)
10.2 Middle East & Africa Hepatitis C Drugs Market Size by Type
10.2.1 Middle East & Africa Hepatitis C Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hepatitis C Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hepatitis C Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Hepatitis C Drugs Market Size by Application
10.3.1 Middle East & Africa Hepatitis C Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hepatitis C Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hepatitis C Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Hepatitis C Drugs Market Size by Country
10.4.1 Middle East & Africa Hepatitis C Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hepatitis C Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Gilead sciences
11.1.1 Gilead sciences Company Details
11.1.2 Gilead sciences Business Overview
11.1.3 Gilead sciences Hepatitis C Drugs Introduction
11.1.4 Gilead sciences Revenue in Hepatitis C Drugs Business (2016-2021)
11.1.5 Gilead sciences Recent Development
11.2 Abbvi
11.2.1 Abbvi Company Details
11.2.2 Abbvi Business Overview
11.2.3 Abbvi Hepatitis C Drugs Introduction
11.2.4 Abbvi Revenue in Hepatitis C Drugs Business (2016-2021)
11.2.5 Abbvi Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Hepatitis C Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Hepatitis C Drugs Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Hepatitis C Drugs Introduction
11.4.4 Merck Revenue in Hepatitis C Drugs Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Details
11.5.2 Glaxosmithkline Business Overview
11.5.3 Glaxosmithkline Hepatitis C Drugs Introduction
11.5.4 Glaxosmithkline Revenue in Hepatitis C Drugs Business (2016-2021)
11.5.5 Glaxosmithkline Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Hepatitis C Drugs Introduction
11.6.4 Novartis Revenue in Hepatitis C Drugs Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Hepatitis C Drugs Introduction
11.7.4 Bristol-Myers Squibb Revenue in Hepatitis C Drugs Business (2016-2021)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Hepatitis C Drugs Introduction
11.8.4 Roche Revenue in Hepatitis C Drugs Business (2016-2021)
11.8.5 Roche Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ C型肝炎治療薬の世界市場規模・現状・予測2021年-2027年(Global Hepatitis C Drugs Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。